ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

58
Analysis
Health Care • New Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bearish•Pacific Edge
•27 Nov 2024 05:06•Broker

Pacific Edge - 1H25 Result — Countdown Is On

Our rating is NEUTRAL. We acknowledge possible positive near-term catalysts, but the LCD decision is binary, and a further equity injection over...

Logo
432 Views
Share
bearish•Pacific Edge
•10 Oct 2024 08:23•Broker

Pacific Edge - Consolidation Mode

Pacific Edge's (PEB) 2Q25 update showed expected softness in lab throughput trends. 2Q25 tests of 7,045 was down -17% versus 2Q24, and slightly...

Logo
356 Views
Share
bullish•Pacific Edge
•22 May 2024 06:39•Broker

Pacific Edge - FY24 Result — Stuck in Neutral

NEUTRAL rating given the LCD outcome is binary and therefore high-risk, lab throughput is subdued, and under any scenario the risk of an equity...

Logo
323 Views
Share
bullish•Pacific Edge
•10 Apr 2024 07:02•Broker

Pacific Edge - 4Q24 — Battening Down the Hatches

Pacific Edge's (PEB) 4Q24 update all but confirmed the halt in momentum, with lab throughput down -19% versus 4Q23 and broadly flat versus 3Q24

Logo
407 Views
Share
bullish•Pacific Edge
•23 Jan 2024 07:05•Broker

Pacific Edge - 3Q24 — Cost and Revenue Decline

Pacific Edge's (PEB) 3Q24 update highlights ongoing softness in lab throughput with -8% year on year and -16% sequential declines as it reduces its...

Logo
308 Views
Share
x